| 000 | 01875 a2200625 4500 | ||
|---|---|---|---|
| 005 | 20250517074113.0 | ||
| 264 | 0 | _c20161230 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1876-4479 | ||
| 024 | 7 |
_a10.1093/ecco-jcc/jjv227 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarthey, L | |
| 245 | 0 | 0 |
_aCancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease. _h[electronic resource] |
| 260 |
_bJournal of Crohn's & colitis _cApr 2016 |
||
| 300 |
_a395-401 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aCTLA-4 Antigen _ximmunology |
| 650 | 0 | 4 | _aColectomy |
| 650 | 0 | 4 |
_aColon _xpathology |
| 650 | 0 | 4 |
_aEnterocolitis _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xadverse effects |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xchemically induced |
| 650 | 0 | 4 | _aIpilimumab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xtherapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMateus, C | |
| 700 | 1 | _aMussini, C | |
| 700 | 1 | _aNachury, M | |
| 700 | 1 | _aNancey, S | |
| 700 | 1 | _aGrange, F | |
| 700 | 1 | _aZallot, C | |
| 700 | 1 | _aPeyrin-Biroulet, L | |
| 700 | 1 | _aRahier, J F | |
| 700 | 1 | _aBourdier de Beauregard, M | |
| 700 | 1 | _aMortier, L | |
| 700 | 1 | _aCoutzac, C | |
| 700 | 1 | _aSoularue, E | |
| 700 | 1 | _aLanoy, E | |
| 700 | 1 | _aKapel, N | |
| 700 | 1 | _aPlanchard, D | |
| 700 | 1 | _aChaput, N | |
| 700 | 1 | _aRobert, C | |
| 700 | 1 | _aCarbonnel, F | |
| 773 | 0 |
_tJournal of Crohn's & colitis _gvol. 10 _gno. 4 _gp. 395-401 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ecco-jcc/jjv227 _zAvailable from publisher's website |
| 999 |
_c25645257 _d25645257 |
||